# The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus

> **NCT06403150** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Dhaka Medical College** · enrollment: 62 (estimated)

## Conditions studied

- Status Epilepticus

## Interventions

- **DRUG:** Levetiracetam Injection
- **DRUG:** Fosphenytoin Injection

## Key facts

- **NCT ID:** NCT06403150
- **Lead sponsor:** Dhaka Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-05-15
- **Primary completion:** 2024-08
- **Final completion:** 2024-10
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06403150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06403150, "The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06403150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*